Inventor
GEHLSEN KURT R
US28 patents
⚠️ This page may combine multiple inventors who share the name “GEHLSEN KURT R”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
MAXIM PHARM INC
13 patentsUS6270781B1Aug 7, 2001
Method and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
MAXIM PHARM INC118 citations98
US6242473B1Jun 5, 2001
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
MAXIM PHARM INC33 citations95
US6350785B2Feb 26, 2002
Methods and compositions for topical treatment of damaged tissue using reactive oxygen metabolite production or release inhibitors
MAXIM PHARM INC25 citations92
US6407133B2Jun 18, 2002
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
MAXIM PHARM INC12 citations81
US6730692B2May 4, 2004
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
MAXIM PHARM INC4 citations73
US6531120B2Mar 11, 2003
Ophthalmic histamine compositions and uses thereof
MAXIM PHARM INC7 citations73
US6221893B1Apr 24, 2001
Administration of histamine for therapeutic purposes
MAXIM PHARM INC5 citations73
US6071942AJun 6, 2000
Elevation of circulating blood histamine levels
MAXIM PHARM INC9 citations73
US6893633B2May 17, 2005
Methods and compositions for promoting the maturation of monocytes
MAXIM PHARM INC8 citations72
US6790440B2Sep 14, 2004
Methods and compositions for promoting the maturation of monocytes
MAXIM PHARM INC7 citations72
US6613788B1Sep 2, 2003
Elevation of circulating blood histamine levels
MAXIM PHARM INC2 citations62
US6462067B1Oct 8, 2002
Treatment and prevention of reactive oxygen metabolite-mediated cellular damage
MAXIM PHARM INC3 citations62
US6821510B2Nov 23, 2004
Methods and compositions for promoting the maturation of monocytes
MAXIM PHARM INC3 citations61
RESEARCH CORPORATION TECH INC
9 patentsUS10329572B2Jun 25, 2019
Pichia pastoris strains for producing predominantly homogeneous glycan structure
RESEARCH CORPORATION TECH INC3 citations82
US11220692B2Jan 11, 2022
Pichia pastoris strains for producing predominantly homogeneous glycan structure
RESEARCH CORPORATION TECH INC1 citations71
US10612033B2Apr 7, 2020
Pichia pastoris strains for producing predominantly homogeneous glycan structure
RESEARCH CORPORATION TECH INC2 citations71
US12359211B2Jul 15, 2025
Pichia pastoris strains for producing predominantly homogeneous glycan structure
RESEARCH CORPORATION TECH INC0 citations60
US11866715B2Jan 9, 2024
Pichia pastoris strains for producing predominantly homogeneous glycan structure
RESEARCH CORPORATION TECH INC0 citations60
US11542321B2Jan 3, 2023
Engineered stable CH2 polypeptides
RESEARCH CORPORATION TECH INC0 citations51
US10113164B2Oct 30, 2018
Pichia pastoris surface display system
RESEARCH CORPORATION TECH INC0 citations50
US9976131B2May 22, 2018
Ribotoxin molecules derived from sarcin and other related fungal ribotoxins
RESEARCH CORPORATION TECH INC0 citations50
US10829558B2Nov 10, 2020
Small antibody-like polypeptides that bind to EPHA2 receptor
RESEARCH CORPORATION TECH INC0 citations36
RES CORP TECH INC
3 patentsUS9617550B2Apr 11, 2017
Pichia pastoris strains for producing predominantly homogeneous glycan structure
RES CORP TECH INC16 citations91
US9603911B2Mar 28, 2017
Ribotoxin molecules derived from sarcin and other related fungal ribotoxins
RES CORP TECH INC1 citations51
US9803210B2Oct 31, 2017
Fusion proteins comprising immunoglobulin constant domain-derived scaffolds
RES CORP TECH INC0 citations49